Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.89
(2.26%)
CNY 5.89
(2.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 177.43 Million CNY | 58.09% |
| 2022 | 167.86 Million CNY | 8.33% |
| 2021 | 154.95 Million CNY | 1.09% |
| 2020 | 153.28 Million CNY | 20.66% |
| 2019 | 127.04 Million CNY | 1.43% |
| 2018 | 125.24 Million CNY | -2.29% |
| 2017 | 128.17 Million CNY | 5.19% |
| 2016 | 121.85 Million CNY | 17.02% |
| 2015 | 104.13 Million CNY | 9.46% |
| 2014 | 95.13 Million CNY | -8.79% |
| 2013 | 104.29 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 55.25 Million CNY | -20.08% |
| 2024 Q3 | 52.02 Million CNY | 12.91% |
| 2024 Q2 | 53.17 Million CNY | -3.77% |
| 2023 Q3 | 52.02 Million CNY | 38.19% |
| 2023 Q4 | 69.13 Million CNY | 32.89% |
| 2023 FY | 265.36 Million CNY | 58.09% |
| 2023 Q1 | 41.26 Million CNY | 6.4% |
| 2023 Q2 | 37.64 Million CNY | -8.75% |
| 2022 Q3 | 52.52 Million CNY | 44.5% |
| 2022 Q1 | 40.21 Million CNY | -3.52% |
| 2022 FY | 167.86 Million CNY | 8.33% |
| 2022 Q4 | 38.77 Million CNY | -26.17% |
| 2022 Q2 | 36.34 Million CNY | -9.62% |
| 2021 FY | 154.95 Million CNY | 1.09% |
| 2021 Q4 | 41.68 Million CNY | 30.4% |
| 2021 Q1 | 38.57 Million CNY | 6.23% |
| 2021 Q2 | 42.73 Million CNY | 10.8% |
| 2021 Q3 | 31.96 Million CNY | -25.21% |
| 2020 Q4 | 36.3 Million CNY | -14.55% |
| 2020 FY | 153.28 Million CNY | 20.66% |
| 2020 Q3 | 42.49 Million CNY | 11.2% |
| 2020 Q2 | 38.21 Million CNY | 5.36% |
| 2020 Q1 | 36.26 Million CNY | 36.83% |
| 2019 Q1 | 38.37 Million CNY | 50.96% |
| 2019 Q4 | 26.5 Million CNY | -22.72% |
| 2019 Q2 | 27.86 Million CNY | -27.4% |
| 2019 Q3 | 34.3 Million CNY | 23.12% |
| 2019 FY | 127.04 Million CNY | 1.43% |
| 2018 Q4 | 25.41 Million CNY | 0.0% |
| 2018 FY | 125.24 Million CNY | -2.29% |
| 2018 Q1 | -61.25 Million CNY | 0.0% |
| 2017 Q2 | 29.87 Million CNY | 0.0% |
| 2017 Q1 | 29.87 Million CNY | -2.99% |
| 2017 FY | 128.17 Million CNY | 5.19% |
| 2016 Q1 | 29 Million CNY | 0.0% |
| 2016 Q3 | 30.78 Million CNY | 6.15% |
| 2016 Q2 | 29 Million CNY | 0.0% |
| 2016 Q4 | 30.78 Million CNY | 0.0% |
| 2016 FY | 121.85 Million CNY | 17.02% |
| 2015 FY | 104.13 Million CNY | 9.46% |
| 2014 FY | 95.13 Million CNY | -8.79% |
| 2013 FY | 104.29 Million CNY | 0.0% |